More Startups
This investment carries considerable risks and may lead to a loss of the entire assets invested. Projected returns cannot be guaranteed and may be lower than expected.

Caterna | Overview

With its certified digital therapy for amblyopia, Caterna is already firmly established in the first health market.
Pitch Video


The Caterna Vision Training is a telemedical procedure developed as a medical product that treats the visual impairment called lazy eye (amblyopia) among children through computer-assisted therapy. 300 doctors have already prescribed our therapy and more than 1,000 patients have already been treated with Caterna Vision Training. 18 health insurance companies already cover the costs. We are now starting the marketing campaign to address affected parents directly.

Caterna - Key Investment Facts

 

About 6% of all children in Germany suffer from the visual impairment called amblyopia. Currently, there are around 400,000 children affected in Germany.

When treating amblyopia with the so-called occlusion therapy, one covers the child's stronger eye with an eye patch in order to train the brain. This conventional method of treatment can take up to 2.5 years.

The therapy does not work for about one-third of the children. Moreover, many children find the patch unpleasant and lose the motivation to wear it.

The digital health startup Caterna solves these problems with its online therapy, which is certified as a medical product and serves as a supplement to the traditional occlusion therapy.

Caterna -

 

The Caterna Vision Training is a computer-assisted therapy in which children play computer games, which have a special wave pattern running in the background, every day for 30-45 minutes.

This wave pattern in the background stimulates the brain to reactivate the connection to the weak eye.

The proof of concept has already been made: Clinical studies show a significant improvement in the child’s vision after being treated with the Caterna therapy.

Since Caterna Vision Training is a telemedical application, children can play the online games conveniently and comfortably from home. Furthermore, Caterna Vision Training has already been launched on the market.

18 health insurance companies already cover the therapy costs ("app on prescription"). This corresponds to 20% of all patients. In our experience, the costs are even reimbursed for approximately 50% of patients in the scope of individual case decisions.

So far, 300 ophthalmologists have prescribed our therapy and have treated more than 1,000 patients with the Caterna Vision Training.

Caterna is financed by the VC Peppermint VenturePartners, which specializes in healthcare startups, and by BFB Brandenburg Kapital GmbH, a subsidiary of the Investment Bank of the State of Brandenburg (ILB), and the KfW.

With the support of its investors, Caterna was able to establish its medical product in the primary healthcare market.

We will use the funds from the financing through Companisto to expand the reach of our online marketing campaign to address affected parents directly and to advance our aim of internationalization.

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:


Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of Caterna.
Already registered?    Log in